News Health & Medicine

U.S. FDA may nix black box warning on some menopause estrogen treatments

The warning on vaginal estrogen is doing harm and is not supported by science, experts say

A box of capsules containing menopause estrogen treatment for vaginal use

Vaginal estrogen products like Imvexxy treat some symptoms of menopause with little risk of dangerous side effects, but carry a black box warning that make many women reconsider using them. The U.S. Food and Drug Administration is considering removing the warning.

Mayne Pharma

By Tina Hesman Saey and Sofia Caetano Avritzer

If a panel convened by the U.S.